Latest News & Features
Big Pharma
Gene-sequencing giant to be punished for defying EC authority by acquiring cancer treatment firm say FT sources | EC concerns over anti-competitive effects could scupper controversial deal. 10 October 2023
Big Pharma
Genexa files lawsuit against KinderFarms relating to agave-based over-the-counter pain relief medicines for children | Accuses KinderFarm of ‘willful, intentional, and deliberate’ actions. 5 October 2023
Biotechnology
Both attorneys have ‘exceptional experience’ in life sciences and previously practised at Dechert. 5 October 2023
Americas
In part 2 of articles assessing the impact of 'Cellect v Samsung', Vincent Shier of Haynes Boone now sets out what the future may hold—both for this unusual case, as well as judicial doctrine in general. 5 October 2023
Big Pharma
Amneal Pharmaceuticals fends off CMP’s US lawsuit alleging infringement of the blood pressure treatment / Dispute centres on whether suspension agents were used in “substantially the same way”. 3 October 2023
Africa
Non-profit hails move but urges other big pharma companies to follow suit | To avoid litigation, manufacturers must ensure generic versions are of good quality, medically acceptable, and are used only in the selected low-and middle-income countries. 3 October 2023
Big Pharma
Teva’s patents protecting migraine drug ruled invalid | Lilly’s motion for a new trial denied | ‘The court does not reach this decision nor overturn a jury verdict lightly’ says Judge Alison Burroughs. 28 September 2023
Big Pharma
A Federal Circuit decision provides lessons on why inaction over patent terms may risk incurable invalidation of important patents, writes Vincent Shier of Haynes Boone. 28 September 2023
Big Pharma
ANDA litigation expert brings chemical, biotech, and pharmaceutical experience to the firm. 26 September 2023
Americas
Agreement reached over intranasal ketamine royalties and patents | Yale and a professor agree to pay $1.5m to the US government and give up royalty rights. 26 September 2023